Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ramzi A Ajjan
Oral Semaglutide in the Management of Type 2 Diabetes: A Report on the Evidence to Date
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Related publications
54-Or: Oral Semaglutide vs. Empagliflozin Added on to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Semaglutide: A New GLP‐1 Analogue for Type 2 Diabetes
Prescriber
Pharmacology
Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients
Drugs in Context
Molecular Medicine
Pharmacology
Exercise for the Management of Type 2 Diabetes: A Review of the Evidence
Acta Diabetologica
Internal Medicine
Medicine
Diabetes
Metabolism
Endocrinology
1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Management of Psoriasis in Pregnancy – A Review of the Evidence to Date
Drugs in Context
Molecular Medicine
Pharmacology
The Oral Microflora in Obesity and Type-2 Diabetes
Journal of Oral Microbiology
Infectious Diseases
Microbiology
Dentistry
Cryoablation in the Management of Breast Cancer: Evidence to Date
Breast Cancer: Targets and Therapy
Oncology
Counterpoint: Evidence-Based Prevention of Type 2 Diabetes: The Power of Lifestyle Management
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes